NCT06529874 Pressure Pain Tolerance in Relation to Balance and Strength in Children
| NCT ID | NCT06529874 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Adly A Adam |
| Condition | Sickle Cell Anemia |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2025-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-02-01 with a primary completion date of 2025-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sickle cell disease (SCD) is the most frequent life-threatening genetic hemoglobinopathy in the world and occurs due to the synthesis of abnormal hemoglobin S (HbS).Cells with sickle cell hemoglobin are stiff and sticky. When they lose their oxygen, they form into the shape of a sickle or crescent. This can cause pain and tissue damage. Significant decrease in exercise capacity was seen in sickle cell anemic children. In the absence of a guidelines that can guide the prescription of exercise in SCD children. This study is a step for determine the forms of prescription of pain on the balance and muscle strength to build up in future studies a safety of physical exercises for children with sickle cell anemia and improve their functional abilities.
Eligibility Criteria
Inclusion Criteria: * Age range range was 9-14 years old. * Could follow given instructions. * Children with Sickle cell anemia were medically stable, and take their medications regularly. * Children with Sickle cell anemia had experience of chronic pain that lasts more than 6 months. * All children with Sickle cell anemia have average weight, height, and body mass index based on their age percentiles. * All normal healthy children did not participating in regular sport activities, particularly including lower limb strengthening. Exclusion Criteria: * Defined cardiovascular or respiratory disorders. * Renal failure. * Myocardial infarction, mainly within last month. * Unstable angina. * Recent thoracoabdominal surgery. * Thoracic or abdominal aneurysm or current pneumothorax. * Painful vaso-occlusive crises. * Muscular contractures, Joints' stiffness, or deformities. * Neuromuscular problems i.e., myositis or peripheral neuropathy.
Contact & Investigator
Shimaa A Ahmed, PHD
STUDY CHAIR
Head of Haematology Dept, Faculty of Medicine, Alexandria University
Frequently Asked Questions
Who can join the NCT06529874 clinical trial?
This trial is open to participants of all sexes, aged 9 Years or older, up to 14 Years, studying Sickle Cell Anemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06529874 currently recruiting?
Yes, NCT06529874 is actively recruiting participants. Contact the research team at malmanakhly10@gmail.com for enrollment information.
Where is the NCT06529874 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT06529874 clinical trial?
NCT06529874 is sponsored by Adly A Adam. The principal investigator is Shimaa A Ahmed, PHD at Head of Haematology Dept, Faculty of Medicine, Alexandria University. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.